Results 141 to 150 of about 7,935 (218)

Prompt Engineering of Large Language Models for Medication Dose Calculation. [PDF]

Clin Pharmacol Ther
Weaver M, Petry NJ, Cauwels J, Lupu RA, Massmann A.   +4 more
europepmc   +1 more source

Treatment persistence after switching between anti-tumor necrosis factor agents and tofacitinib in ulcerative colitis: A nationwide claims-based cohort study in South Korea. [PDF]

Ther Adv Gastroenterol
Baek JE, Choi A, Lee HH, Lee BI, Lee KM.
europepmc   +1 more source

Pharmacogenetic Risk Factors for Thiopurine-Induced Leukopenia in Patients with Inflammatory Bowel Disease. [PDF]

Yonsei Med J
Boo EK, Yu J, Oh S, Cheon JH, Kim JH.
europepmc   +1 more source

AGA Living Clinical Practice Guideline on the Pharmacologic Management of Moderate-to-Severe Crohn's Disease. [PDF]

Gastroenterology
Scott FI, Ananthakrishnan AN, Click B, Agrawal M, Syal G, Haydek JP, Yuan Y, Kappelman MD, Lewis JD, Singh S.   +9 more
europepmc   +1 more source

Management of Inflammatory Bowel Disease with History of Cancer. [PDF]

Cancers (Basel)
Annese V, Parisi M, Cinque S, Cappellini A, Biamonte P, Dell'Anna G, Testoni SGG, Annunziata ML.   +7 more
europepmc   +1 more source

Adverse Events Related to Azathioprine Use in Patients With Inflammatory Bowel Disease: A Real-World Cohort Study. [PDF]

Gastroenterol Res Pract
Ranjan MK, Neupane P, Maharjan B, Lamsal M, Poudel B.   +4 more
europepmc   +1 more source

NUDT5 regulates purine metabolism and thiopurine sensitivity by interacting with PPAT. [PDF]

Science
Wu Z, Nguyen PT, Sondhi V, Yao RW, Lu Z, Dai T, Chiang JC, Cai F, Williams IM, Blatt EB, Shang Z, Cai L, Zhang J, Moore MD, Alshamleh I, Li X, Ogu T, Zacharias LG, Winston R, Patricio JS, Johnson X, Chen WM, Cong Q, Mathews TP, Zhang Y, Zhang L, DeBerardinis RJ.   +26 more
europepmc   +1 more source

Beyond Colectomy-Interpreting Long-Term Disease Burden and Clinical Trajectories in Moderate-to-Severe Ulcerative Colitis. [PDF]

J Gastroenterol Hepatol
Lee CK.
europepmc   +1 more source

Therapeutic Drug Monitoring and Pharmacogenomics of Thiopurines in Inflammatory Bowel Disease: International Guidelines Revisited. [PDF]

Ther Drug Monit
Bayoumy AB, Derijks LJJ, de Boer NKH.
europepmc   +1 more source